Combined use of oestradiol and progesterone to support luteal phase in antagonist intracytoplasmic sperm injection cycles of normoresponder women: a case-control study-Reference-Cited by-同舟云学术

Combined use of oestradiol and progesterone to support luteal phase in antagonist intracytoplasmic sperm injection cycles of normoresponder women: a case-control study

Published:2019-08-28 Issue:2 Volume:40 Page:264-269
ISSN:0144-3615
Container-title:Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Journal of Obstetrics and Gynaecology

Author:

Çakar Erbil¹,Tasan Habibe Ayvaci¹^ORCID,Kumru Pınar¹,Cogendez Ebru¹^ORCID,Usal Nazan Tarhan¹,Kutlu Hüseyin Tayfun¹,Özkaya Enis¹,Eser Semra Kayatas¹

Affiliation:

1. Zeynep Kamil Women and Children's Diseases Training and Research Hospital, IVF Center, Istanbul, Turkey

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01443615.2019.1631765

Reference24 articles.

1. Estradiol supplementation during the luteal phase in poor responder patients undergoing in vitro fertilization: a randomized clinical trial

2. Use of luteal estrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study

3. Practice Bulletin No. 150

4. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoingin vitrofertilization/intracytoplasmic sperm injection–embryo transfer

5. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the optimal luteal support in assisted reproductive technology?;Hormone Molecular Biology and Clinical Investigation;2021-02-18

2. Is there any correlation between Estradiol supplementation, as luteal phase support, and clinical pregnancy in ART cycles? A cross-sectional study;International Journal of Reproductive BioMedicine (IJRM);2020-11-22